Clinical Trial Update: A Study of MHB048C in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MHB048C in patients with metastatic castration-resistant prostate cancer and advanced solid tumors; Phase 1/2, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Solid Tumor

Drugs mentioned

• MHB048C

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING